Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
87.99
+0.88 (+1.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
February 07, 2022
Gainers Agile Therapeutics (NASDAQ:AGRX) ...
Via
Benzinga
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics
February 02, 2022
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
Gainers ContraFect (NASDAQ:CFRX) stock mo...
Via
Benzinga
2 Top Biotech Stocks Ready for a Bull Run
November 24, 2021
Both of these companies have potential catalysts on the way.
Via
The Motley Fool
Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript
November 08, 2021
AXSM earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Axsome Therapeutics Stock Is Rising Today
November 08, 2021
The company provided its third-quarter update.
Via
The Motley Fool
2 Biotech Stocks Poised for Jaw-Dropping Growth
October 17, 2021
These two tiny drugmakers could make early shareholders wealthy.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Why Axsome Therapeutics Stock Rocketed Higher This Week
October 15, 2021
Optimism among investors is growing for the possible approval of the biotech's MDD drug.
Via
The Motley Fool
1 Beaten-Down Stock With 10X Potential
October 14, 2021
This biotech is down, but it isn't out just yet.
Via
The Motley Fool
45 Biggest Movers From Yesterday
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
Why Axsome Therapeutics Stock Caught Fire in September
October 06, 2021
This beaten-down biotech regained some lost ground last month.
Via
The Motley Fool
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shareholder Notice: Investigation over Possible Wrongdoing
September 29, 2021
San Diego, CA -- (SBWIRE) -- 09/29/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Axsome Therapeutics, Inc.
Via
SBWire
Exposures
Product Safety
Why Wall Street Thinks This Biotech Stock Can Triple Your Money
September 23, 2021
The risks are huge, but so are the potential returns.
Via
The Motley Fool
Why Axsome Therapeutics Stock Cratered in August
September 08, 2021
An unexpected regulatory setback weighed heavily on the biotech's shares last month.
Via
The Motley Fool
3 Healthcare Stocks That Might Skyrocket When COVID Is Over
September 07, 2021
Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over?
Via
The Motley Fool
Exposures
COVID-19
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
September 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?
September 05, 2021
There are still plenty of unknowns related to Axsome's FDA filing.
Via
The Motley Fool
Exposures
Product Safety
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
3 Biotech Stocks That Are Too Cheap to Ignore
September 02, 2021
You'll definitely want to check out these biotech bargains.
Via
The Motley Fool
Here's Why Axsome Therapeutics Stock Is Surging Today
September 01, 2021
The company still doesn't have much to say about the FDA and its experimental new anti-depression drug.
Via
The Motley Fool
Exposures
Product Safety
10 Biggest Price Target Changes For Monday
August 30, 2021
Barclays raised Affirm Holdings, Inc. (NASDAQ:AFRM
Via
Benzinga
Which Biotech Stock Will Shock the Market in 2022?
August 27, 2021
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
Via
The Motley Fool
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shareholder Notice: Investigation over Possible Violations of Securities Laws
August 26, 2021
San Diego, CA -- (SBWIRE) -- 08/26/2021 -- Axsome Therapeutics, Inc is under investigation concerning possible securities laws violations in connection with certain financial statements.
Via
SBWire
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 24, 2021
Gainers Regencell Bioscience (NASDAQ:RGC)...
Via
Benzinga
Why Axsome Therapeutics Stock Is Jumping Today
August 23, 2021
Investors are happy that the FDA didn't ask for more information to supplement Axsome's regulatory filing for AXS-05.
Via
The Motley Fool
Exposures
Product Safety
Why Is Axsome Therapeutics (AXSM) Stock Shooting Higher On Monday?
August 23, 2021
Axsome Therapeutics Inc (NASDAQ: AXSM) stock is rising in premarket due to an update for its US marketing application seeking approval for AXS-05 for major...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 23, 2021
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The market value of their outstanding shares is at $144...
Via
Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
Could Biogen Acquire Axsome Therapeutics?
August 20, 2021
Here are three reasons why a buyout just might happen.
Via
The Motley Fool
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.